NCT00116792View on ClinicalTrials.gov

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2004

Conditions
Coronary Artery DiseaseDiabetes Mellitus
Interventions
PROCEDURE

Percutaneous Coronary Intervention (PCI)

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Guidant Corporation
All Listed Sponsors
collaborator

Guidant Corporation

INDUSTRY

lead

Gold, Herman K., MD

INDIV